Study: Stem cell transplants reduce diabetics' insulin reliance

04/14/2009 | Yahoo!

In a U.S. study, 20 of 23 patients with Type 1 diabetes did not need to take daily insulin therapy for four years after receiving transplants of bone marrow-derived stem cells. The study also found that the patients were able to maintain the increase in levels of C-peptides, an indicator for insulin production, for at least three years.

View Full Article in:

Yahoo!

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY